Bai Zhongquan, chairman of China National Pharmaceutical Group Co Ltd (Sinopharm), met with Hebei Governor Wang Zhengpu, in Langfang, Hebei province, on June 15.

Bai Zhongquan, chairman of Sinopharm, meets with Hebei Governor Wang Zhengpu, in Langfang, Hebei province, on June 15. [Photo/sinopharm.com]

After welcoming Bai and his delegation, Wang expressed gratitude to Sinopharm for its contributions to Hebei's economic and social development.

Wang said that Hebei is fully promoting the coordinated development of the Beijing-Tianjin-Hebei region and the construction of Xiong'an New Area, and strengthening the deep integration of technological and industrial innovation. Multiple measures are being taken to accelerate the development of new quality productive forces.

Wang hopes that Sinopharm will increase its investment in his province, promoting the establishment of more new business formats and projects in the pharmaceutical and healthcare fields. Hebei will continue to create a favorable business environment to support Sinopharm's development there.

Bai expressed gratitude to the Hebei provincial and local governments for their care and support for Sinopharm's subsidiaries in the region. He briefly gave an overview of the group and its recent operational performance.

He noted that Hebei is actively developing strategic emerging industries like biomedicine and building a modern commercial and logistics hub. The foundation of past cooperation between the two sides is strong, and there is ample room for future collaboration.

Bai said that Sinopharm is committed to implementing the national strategy for regional development and industry policies, fully leveraging its advantages across the entire pharmaceutical and healthcare industry chain.

The group is continuously making efforts in scientific research and innovation, industrial manufacturing, and commercial circulation, he said, adding that Sinopharm will actively promote comprehensive cooperation with Hebei province to better serve the high-quality development of Hebei's biomedicine industry.

The meeting was also attended by Shi Qingshuang, vice-governor of Hebei, Jin Bin, deputy general manager of Sinopharm, Zhu Haowen, secretary-general of the Hebei provincial government, principal leaders of the cities of Qinhuangdao, Langfang and Xingtai.

Other participants included officials from Xiong'an New Area, the provincial development and reform commission, the province’s department of commerce and the provincial State-owned Assets Supervision and Administration Commission, and heads of relevant departments of Sinopharm headquarters, Sinopharm International, Tiantan Biological Products and key Sinopharm subsidiaries in Hebei.